On the other hand, the frequencies of MAGE-A1 and MAGE-A3 expression in different astrocytomas and glioblastomas have been demonstrated to vary in range from 0 to 30% [58–60]. Here, MAGEA3 is linked to astrocytoma (excluding glioblastoma).